SubscribeSign In
LeaderPortfolio
Billionaire Profile
C
Global Rank
#460

Image: Linné, Carl von, 1707-1778 Devillers, Charles, 1724-1809 Crawford, J. C., former owner. DSI Buchanan, Lee LaForest, b. 1893, former owner. DSI Schaus, William, 1859- , former owner. DSI Aldrich, John Merton, 1866-1934, former owner. DSI Melander, A. L. (Axel Leonard), b. 1878, former owner. DSI U.S. Dept. of the Interior. Library, former owner. DSI | Public domain | via Wikimedia Commons

Cen Junda

CEO, Pharmaceuticals
CHINA
Real-Time Net Worth
$7.907B
Estimated based on Pharmaceuticals stock value as of April 21, 2026
+0.23% (24h)
Age
61
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
CHINA

Biography

Cen Junda is a prominent figure in the Chinese pharmaceutical industry, renowned for his strategic investments and significant wealth. His estimated net worth, as of March 24, 2026, is $6.6 Billion. Cen Junda's fortune is primarily derived from his substantial stakes in Jiangsu Hengrui Pharmaceuticals and Hansoh Pharmaceutical Group, both key players in China's healthcare sector. His career is marked by a deep understanding of the pharmaceutical industry, which he leveraged to identify and support promising ventures. Cen Junda's influence extends beyond personal wealth, contributing to the growth and innovation within China's biopharma market.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/21/2026

Wealth Over Time

In-Depth Profile

Early Life and Education

Cen Junda's early life and background are not widely detailed in public sources. However, it's known that he holds degrees from Zhejiang University and the China State Institute of Pharmaceutical Industry. This educational foundation provided him with the technical expertise to understand the pharmaceutical sector deeply.

Rise to Success

Cen Junda's rise to prominence is directly linked to his strategic investments in the pharmaceutical industry. He recognized the potential of companies like Jiangsu Hengrui Medicine and Hansoh Pharmaceutical Group early on. His investments proved highly lucrative as these companies grew and innovated in the market. His financial success is tied to the massive appreciation of his equity in these companies following their successful commercialization of innovative drugs.

Key Business Strategies

Cen Junda's key business strategy revolves around identifying and investing in high-potential pharmaceutical companies. He appears to focus on companies with strong research and development capabilities, especially in areas like oncology and metabolic diseases. His investment approach aligns with the long-term growth of the companies he backs.

Philanthropy

There is no readily available information about Cen Junda's philanthropic activities.

Career Milestones

1990

Investment in Jiangsu Hengrui Medicine

Made a strategic investment in Jiangsu Hengrui Medicine, contributing to the company's growth as a major pharmaceutical player.

1995

Investment in Hansoh Pharmaceutical Group

Made a strategic investment in Hansoh Pharmaceutical Group, contributing to the company's growth as a major pharmaceutical player.

Compare Cen Junda

Net Worth Face-off
Cen Junda vs Elon Musk
Compare Wealth →
Net Worth Face-off
Cen Junda vs Jeff Bezos
Compare Wealth →
Net Worth Face-off
Cen Junda vs Mark Zuckerberg
Compare Wealth →